The Market Reports

Index

1 Nuclear Medicine Radioisotopes Market Overview
1.1 Product Overview and Scope of Nuclear Medicine Radioisotopes
1.2 Nuclear Medicine Radioisotopes Segment by Type
1.2.1 Global Nuclear Medicine Radioisotopes Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Thallium-201 (Tl-201)
1.2.3 Iodine (I-123)
1.2.4 Fluorine-18
1.2.5 Rubidium-82 (Rb-82)
1.2.6 Other
1.3 Nuclear Medicine Radioisotopes Segment by Application
1.3.1 Global Nuclear Medicine Radioisotopes Sales Comparison by Application: (2021-2027)
1.3.2 Tumor
1.3.3 Heart Disease
1.3.4 Lymphoma
1.3.5 Thyroid Gland
1.3.6 Other
1.4 Global Nuclear Medicine Radioisotopes Market Size Estimates and Forecasts
1.4.1 Global Nuclear Medicine Radioisotopes Revenue 2016-2027
1.4.2 Global Nuclear Medicine Radioisotopes Sales 2016-2027
1.4.3 Nuclear Medicine Radioisotopes Market Size by Region: 2016 Versus 2021 Versus 2027

2 Nuclear Medicine Radioisotopes Market Competition by Manufacturers
2.1 Global Nuclear Medicine Radioisotopes Sales Market Share by Manufacturers (2016-2021)
2.2 Global Nuclear Medicine Radioisotopes Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Nuclear Medicine Radioisotopes Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Nuclear Medicine Radioisotopes Manufacturing Sites, Area Served, Product Type
2.5 Nuclear Medicine Radioisotopes Market Competitive Situation and Trends
2.5.1 Nuclear Medicine Radioisotopes Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Nuclear Medicine Radioisotopes Players Market Share by Revenue
2.5.3 Global Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Nuclear Medicine Radioisotopes Retrospective Market Scenario by Region
3.1 Global Nuclear Medicine Radioisotopes Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Nuclear Medicine Radioisotopes Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Nuclear Medicine Radioisotopes Market Facts & Figures by Country
3.3.1 North America Nuclear Medicine Radioisotopes Sales by Country
3.3.2 North America Nuclear Medicine Radioisotopes Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Nuclear Medicine Radioisotopes Market Facts & Figures by Country
3.4.1 Europe Nuclear Medicine Radioisotopes Sales by Country
3.4.2 Europe Nuclear Medicine Radioisotopes Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Nuclear Medicine Radioisotopes Market Facts & Figures by Region
3.5.1 Asia Pacific Nuclear Medicine Radioisotopes Sales by Region
3.5.2 Asia Pacific Nuclear Medicine Radioisotopes Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Nuclear Medicine Radioisotopes Market Facts & Figures by Country
3.6.1 Latin America Nuclear Medicine Radioisotopes Sales by Country
3.6.2 Latin America Nuclear Medicine Radioisotopes Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Nuclear Medicine Radioisotopes Market Facts & Figures by Country
3.7.1 Middle East and Africa Nuclear Medicine Radioisotopes Sales by Country
3.7.2 Middle East and Africa Nuclear Medicine Radioisotopes Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Nuclear Medicine Radioisotopes Historic Market Analysis by Type
4.1 Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2016-2021)
4.2 Global Nuclear Medicine Radioisotopes Revenue Market Share by Type (2016-2021)
4.3 Global Nuclear Medicine Radioisotopes Price by Type (2016-2021)

5 Global Nuclear Medicine Radioisotopes Historic Market Analysis by Application
5.1 Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2016-2021)
5.2 Global Nuclear Medicine Radioisotopes Revenue Market Share by Application (2016-2021)
5.3 Global Nuclear Medicine Radioisotopes Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Agfa-Gevaert Group
6.1.1 Agfa-Gevaert Group Corporation Information
6.1.2 Agfa-Gevaert Group Description and Business Overview
6.1.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Portfolio
6.1.5 Agfa-Gevaert Group Recent Developments/Updates
6.2 Braco
6.2.1 Braco Corporation Information
6.2.2 Braco Description and Business Overview
6.2.3 Braco Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Braco Nuclear Medicine Radioisotopes Product Portfolio
6.2.5 Braco Recent Developments/Updates
6.3 Cardiarc
6.3.1 Cardiarc Corporation Information
6.3.2 Cardiarc Description and Business Overview
6.3.3 Cardiarc Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Cardiarc Nuclear Medicine Radioisotopes Product Portfolio
6.3.5 Cardiarc Recent Developments/Updates
6.4 Cardinal Health
6.4.1 Cardinal Health Corporation Information
6.4.2 Cardinal Health Description and Business Overview
6.4.3 Cardinal Health Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Cardinal Health Nuclear Medicine Radioisotopes Product Portfolio
6.4.5 Cardinal Health Recent Developments/Updates
6.5 CMR Naviscan (Gamma Medica Inc.)
6.5.1 CMR Naviscan (Gamma Medica Inc.) Corporation Information
6.5.2 CMR Naviscan (Gamma Medica Inc.) Description and Business Overview
6.5.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
6.5.4 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Portfolio
6.5.5 CMR Naviscan (Gamma Medica Inc.) Recent Developments/Updates
6.6 Curium
6.6.1 Curium Corporation Information
6.6.2 Curium Description and Business Overview
6.6.3 Curium Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Curium Nuclear Medicine Radioisotopes Product Portfolio
6.6.5 Curium Recent Developments/Updates
6.7 Digirad
6.6.1 Digirad Corporation Information
6.6.2 Digirad Description and Business Overview
6.6.3 Digirad Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Digirad Nuclear Medicine Radioisotopes Product Portfolio
6.7.5 Digirad Recent Developments/Updates
6.8 GE Healthcare
6.8.1 GE Healthcare Corporation Information
6.8.2 GE Healthcare Description and Business Overview
6.8.3 GE Healthcare Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
6.8.4 GE Healthcare Nuclear Medicine Radioisotopes Product Portfolio
6.8.5 GE Healthcare Recent Developments/Updates
6.9 Nordion (Canada)
6.9.1 Nordion (Canada) Corporation Information
6.9.2 Nordion (Canada) Description and Business Overview
6.9.3 Nordion (Canada) Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Nordion (Canada) Nuclear Medicine Radioisotopes Product Portfolio
6.9.5 Nordion (Canada) Recent Developments/Updates
6.10 NTP Radioisotopes SOC
6.10.1 NTP Radioisotopes SOC Corporation Information
6.10.2 NTP Radioisotopes SOC Description and Business Overview
6.10.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
6.10.4 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Portfolio
6.10.5 NTP Radioisotopes SOC Recent Developments/Updates
6.11 Positron
6.11.1 Positron Corporation Information
6.11.2 Positron Nuclear Medicine Radioisotopes Description and Business Overview
6.11.3 Positron Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Positron Nuclear Medicine Radioisotopes Product Portfolio
6.11.5 Positron Recent Developments/Updates
6.12 Segami
6.12.1 Segami Corporation Information
6.12.2 Segami Nuclear Medicine Radioisotopes Description and Business Overview
6.12.3 Segami Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Segami Nuclear Medicine Radioisotopes Product Portfolio
6.12.5 Segami Recent Developments/Updates
6.13 Siemens Healthcare
6.13.1 Siemens Healthcare Corporation Information
6.13.2 Siemens Healthcare Nuclear Medicine Radioisotopes Description and Business Overview
6.13.3 Siemens Healthcare Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Siemens Healthcare Nuclear Medicine Radioisotopes Product Portfolio
6.13.5 Siemens Healthcare Recent Developments/Updates

7 Nuclear Medicine Radioisotopes Manufacturing Cost Analysis
7.1 Nuclear Medicine Radioisotopes Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Nuclear Medicine Radioisotopes
7.4 Nuclear Medicine Radioisotopes Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Nuclear Medicine Radioisotopes Distributors List
8.3 Nuclear Medicine Radioisotopes Customers

9 Nuclear Medicine Radioisotopes Market Dynamics
9.1 Nuclear Medicine Radioisotopes Industry Trends
9.2 Nuclear Medicine Radioisotopes Growth Drivers
9.3 Nuclear Medicine Radioisotopes Market Challenges
9.4 Nuclear Medicine Radioisotopes Market Restraints

10 Global Market Forecast
10.1 Nuclear Medicine Radioisotopes Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Nuclear Medicine Radioisotopes by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Nuclear Medicine Radioisotopes by Type (2022-2027)
10.2 Nuclear Medicine Radioisotopes Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Nuclear Medicine Radioisotopes by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Nuclear Medicine Radioisotopes by Application (2022-2027)
10.3 Nuclear Medicine Radioisotopes Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Nuclear Medicine Radioisotopes by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Nuclear Medicine Radioisotopes by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Nuclear Medicine Radioisotopes Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Nuclear Medicine Radioisotopes Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Nuclear Medicine Radioisotopes Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Nuclear Medicine Radioisotopes Covered in This Study
Table 5. Global Nuclear Medicine Radioisotopes Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Nuclear Medicine Radioisotopes Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Nuclear Medicine Radioisotopes Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Nuclear Medicine Radioisotopes Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Nuclear Medicine Radioisotopes Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Nuclear Medicine Radioisotopes Manufacturing Sites and Area Served
Table 11. Manufacturers Nuclear Medicine Radioisotopes Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Nuclear Medicine Radioisotopes by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine Radioisotopes as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Nuclear Medicine Radioisotopes Sales by Region (2016-2021) & (K Units)
Table 16. Global Nuclear Medicine Radioisotopes Sales Market Share by Region (2016-2021)
Table 17. Global Nuclear Medicine Radioisotopes Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Nuclear Medicine Radioisotopes Sales by Country (2016-2021) & (K Units)
Table 19. North America Nuclear Medicine Radioisotopes Sales Market Share by Country (2016-2021)
Table 20. North America Nuclear Medicine Radioisotopes Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Nuclear Medicine Radioisotopes Revenue Market Share by Country (2016-2021)
Table 22. Europe Nuclear Medicine Radioisotopes Sales by Country (2016-2021) & (K Units)
Table 23. Europe Nuclear Medicine Radioisotopes Sales Market Share by Country (2016-2021)
Table 24. Europe Nuclear Medicine Radioisotopes Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Nuclear Medicine Radioisotopes Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Nuclear Medicine Radioisotopes Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Nuclear Medicine Radioisotopes Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Nuclear Medicine Radioisotopes Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Nuclear Medicine Radioisotopes Revenue Market Share by Region (2016-2021)
Table 30. Latin America Nuclear Medicine Radioisotopes Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Nuclear Medicine Radioisotopes Sales Market Share by Country (2016-2021)
Table 32. Latin America Nuclear Medicine Radioisotopes Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Nuclear Medicine Radioisotopes Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Nuclear Medicine Radioisotopes Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Nuclear Medicine Radioisotopes Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Nuclear Medicine Radioisotopes Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Nuclear Medicine Radioisotopes Revenue Market Share by Country (2016-2021)
Table 38. Global Nuclear Medicine Radioisotopes Sales (K Units) by Type (2016-2021)
Table 39. Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2016-2021)
Table 40. Global Nuclear Medicine Radioisotopes Revenue (Million US$) by Type (2016-2021)
Table 41. Global Nuclear Medicine Radioisotopes Revenue Share by Type (2016-2021)
Table 42. Global Nuclear Medicine Radioisotopes Price (USD/Unit) by Type (2016-2021)
Table 43. Global Nuclear Medicine Radioisotopes Sales (K Units) by Application (2016-2021)
Table 44. Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2016-2021)
Table 45. Global Nuclear Medicine Radioisotopes Revenue (Million US$) by Application (2016-2021)
Table 46. Global Nuclear Medicine Radioisotopes Revenue Share by Application (2016-2021)
Table 47. Global Nuclear Medicine Radioisotopes Price (USD/Unit) by Application (2016-2021)
Table 48. Agfa-Gevaert Group Corporation Information
Table 49. Agfa-Gevaert Group Description and Business Overview
Table 50. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product
Table 52. Agfa-Gevaert Group Recent Developments/Updates
Table 53. Braco Corporation Information
Table 54. Braco Description and Business Overview
Table 55. Braco Nuclear Medicine Radioisotopes Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Braco Nuclear Medicine Radioisotopes Product
Table 57. Braco Recent Developments/Updates
Table 58. Cardiarc Corporation Information
Table 59. Cardiarc Description and Business Overview
Table 60. Cardiarc Nuclear Medicine Radioisotopes Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Cardiarc Nuclear Medicine Radioisotopes Product
Table 62. Cardiarc Recent Developments/Updates
Table 63. Cardinal Health Corporation Information
Table 64. Cardinal Health Description and Business Overview
Table 65. Cardinal Health Nuclear Medicine Radioisotopes Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Cardinal Health Nuclear Medicine Radioisotopes Product
Table 67. Cardinal Health Recent Developments/Updates
Table 68. CMR Naviscan (Gamma Medica Inc.) Corporation Information
Table 69. CMR Naviscan (Gamma Medica Inc.) Description and Business Overview
Table 70. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product
Table 72. CMR Naviscan (Gamma Medica Inc.) Recent Developments/Updates
Table 73. Curium Corporation Information
Table 74. Curium Description and Business Overview
Table 75. Curium Nuclear Medicine Radioisotopes Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Curium Nuclear Medicine Radioisotopes Product
Table 77. Curium Recent Developments/Updates
Table 78. Digirad Corporation Information
Table 79. Digirad Description and Business Overview
Table 80. Digirad Nuclear Medicine Radioisotopes Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Digirad Nuclear Medicine Radioisotopes Product
Table 82. Digirad Recent Developments/Updates
Table 83. GE Healthcare Corporation Information
Table 84. GE Healthcare Description and Business Overview
Table 85. GE Healthcare Nuclear Medicine Radioisotopes Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. GE Healthcare Nuclear Medicine Radioisotopes Product
Table 87. GE Healthcare Recent Developments/Updates
Table 88. Nordion (Canada) Corporation Information
Table 89. Nordion (Canada) Description and Business Overview
Table 90. Nordion (Canada) Nuclear Medicine Radioisotopes Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Nordion (Canada) Nuclear Medicine Radioisotopes Product
Table 92. Nordion (Canada) Recent Developments/Updates
Table 93. NTP Radioisotopes SOC Corporation Information
Table 94. NTP Radioisotopes SOC Description and Business Overview
Table 95. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product
Table 97. NTP Radioisotopes SOC Recent Developments/Updates
Table 98. Positron Corporation Information
Table 99. Positron Description and Business Overview
Table 100. Positron Nuclear Medicine Radioisotopes Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Positron Nuclear Medicine Radioisotopes Product
Table 102. Positron Recent Developments/Updates
Table 103. Segami Corporation Information
Table 104. Segami Description and Business Overview
Table 105. Segami Nuclear Medicine Radioisotopes Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Segami Nuclear Medicine Radioisotopes Product
Table 107. Segami Recent Developments/Updates
Table 108. Siemens Healthcare Corporation Information
Table 109. Siemens Healthcare Description and Business Overview
Table 110. Siemens Healthcare Nuclear Medicine Radioisotopes Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Siemens Healthcare Nuclear Medicine Radioisotopes Product
Table 112. Siemens Healthcare Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Nuclear Medicine Radioisotopes Distributors List
Table 116. Nuclear Medicine Radioisotopes Customers List
Table 117. Nuclear Medicine Radioisotopes Market Trends
Table 118. Nuclear Medicine Radioisotopes Growth Drivers
Table 119. Nuclear Medicine Radioisotopes Market Challenges
Table 120. Nuclear Medicine Radioisotopes Market Restraints
Table 121. Global Nuclear Medicine Radioisotopes Sales Forecast by Type (2022-2027) & (K Units)
Table 122. Global Nuclear Medicine Radioisotopes Sales Market Share Forecast by Type (2022-2027)
Table 123. Global Nuclear Medicine Radioisotopes Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 124. Global Nuclear Medicine Radioisotopes Revenue Market Share Forecast by Type (2022-2027)
Table 125. Global Nuclear Medicine Radioisotopes Sales Forecast by Application (2022-2027) & (K Units)
Table 126. Global Nuclear Medicine Radioisotopes Sales Market Share Forecast by Application (2022-2027)
Table 127. Global Nuclear Medicine Radioisotopes Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 128. Global Nuclear Medicine Radioisotopes Revenue Market Share Forecast by Application (2022-2027)
Table 129. Global Nuclear Medicine Radioisotopes Sales Forecast by Region (2022-2027) & (K Units)
Table 130. Global Nuclear Medicine Radioisotopes Sales Market Share Forecast by Region (2022-2027)
Table 131. Global Nuclear Medicine Radioisotopes Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 132. Global Nuclear Medicine Radioisotopes Revenue Market Share Forecast by Region (2022-2027)
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nuclear Medicine Radioisotopes
Figure 2. Global Nuclear Medicine Radioisotopes Market Share by Type in 2020 & 2027
Figure 3. Thallium-201 (Tl-201) Product Picture
Figure 4. Iodine (I-123) Product Picture
Figure 5. Fluorine-18 Product Picture
Figure 6. Rubidium-82 (Rb-82) Product Picture
Figure 7. Other Product Picture
Figure 8. Global Nuclear Medicine Radioisotopes Market Share by Application in 2020 & 2027
Figure 9. Tumor
Figure 10. Heart Disease
Figure 11. Lymphoma
Figure 12. Thyroid Gland
Figure 13. Other
Figure 14. Global Nuclear Medicine Radioisotopes Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Nuclear Medicine Radioisotopes Market Size 2016-2027 (US$ Million)
Figure 16. Global Nuclear Medicine Radioisotopes Sales 2016-2027 (K Units)
Figure 17. Global Nuclear Medicine Radioisotopes Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 18. Nuclear Medicine Radioisotopes Sales Share by Manufacturers in 2020
Figure 19. Global Nuclear Medicine Radioisotopes Revenue Share by Manufacturers in 2020
Figure 20. The Global 5 and 10 Largest Nuclear Medicine Radioisotopes Players: Market Share by Revenue in 2020
Figure 21. Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 22. Global Nuclear Medicine Radioisotopes Sales Market Share by Region (2016-2021)
Figure 23. Global Nuclear Medicine Radioisotopes Sales Market Share by Region in 2020
Figure 24. Global Nuclear Medicine Radioisotopes Revenue Market Share by Region (2016-2021)
Figure 25. Global Nuclear Medicine Radioisotopes Revenue Market Share by Region in 2020
Figure 26. U.S. Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Canada Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Germany Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. France Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. U.K. Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Italy Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Russia Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Japan Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. South Korea Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. India Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Australia Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Taiwan Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Indonesia Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Thailand Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Malaysia Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Philippines Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Vietnam Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Mexico Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Brazil Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Argentina Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Turkey Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Saudi Arabia Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. U.A.E Nuclear Medicine Radioisotopes Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Sales Market Share of Nuclear Medicine Radioisotopes by Type (2016-2021)
Figure 51. Sales Market Share of Nuclear Medicine Radioisotopes by Application (2016-2021)
Figure 52. Sales Market Share of Nuclear Medicine Radioisotopes by Application in 2020
Figure 53. Revenue Share of Nuclear Medicine Radioisotopes by Application (2016-2021)
Figure 54. Revenue Share of Nuclear Medicine Radioisotopes by Application in 2020
Figure 55. Manufacturing Cost Structure of Nuclear Medicine Radioisotopes
Figure 56. Manufacturing Process Analysis of Nuclear Medicine Radioisotopes
Figure 57. Nuclear Medicine Radioisotopes Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed